Lower OGN expression, frequently observed in both PCOS and OC tissues, was associated with altered hormone signaling and poor prognosis, potentially promoting tumor progression through dysregulation of FSHR and m6A methylation. Here, OGN is linked to polycystic ovary syndrome.